Fig. 1From: Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancerThe cumulative survival rate for all patients after completion of chemoradiation. a The cumulative overall survival rate for all patients after completion of chemoradiation, b The cumulative local progression-free survival rate, c The cumulative distant progression-free survival rateBack to article page